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SUMMARY
Dental pulp stem cells (DPSCs) as postnatal stem cells have recently 
been described. They are clonogenic cells, capable for self-renewal with 
high proliferative potential. Their multilineage potential and plasticity 
enables their differentiation into different kind of cells, such as osteoblasts, 
chondrocytes, adipocytes, muscle cells, neural cells, odontoblasts, 
cementoblasts and ameloblasts. DPSCs are an important human stem 
cells source, especially in patients who lost their chance for umbilical 
cord blood isolation and preservation. As these cells became useful for 
tissue engineering and cell therapy, proper mode of their preservation also 
became important. The most important points in the cryopreservation and 
recovery procedure are: growth phase of harvested cells, number of cells, 
the proper cryopreservative concentration and serum concentration. The 
cryopreservation process includes the following general components: 
harvesting of the cells, addition of cryopreservative, the freezing 
procedure, the thawing procedure and assessment of the viability prior to 
transplantation. There is no single and perfect cryopreservation method. 
Further investigations should be regarding capability of DPSCs and their 
differentiated cells to recover and restart proliferation, differentiation and 
new tissue production  for therapeutic use after cryopreservation.
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Postnatal Stem Cells and Their 
Potential Use in Dentistry
Postnatal stem cells are defined as clonogenic cells 
capable for self-renewal and multilinear differentiation1,2. 
They play a significant role in tissue repair and 
regeneration3. Advances in stem cell biology and gene 
therapy technology have provided the great potential of 
postnatal stem cells for use in regenerative dentistry4-6. 
Recent investigations identified and characterized stem 
cells from dental tissues, such as: dental epithelium, dental 
papilla, dental pulp, periodontal ligament and dental 
follicle3,4,7,8. Dental pulp stem cells have recently been 
described as similar to bone marrow stem cells regarding 
their gene expression profiles and expression of cell 
markers9,10. Even though dental pulp stem cells have not 
been as widely studied as bone marrow stem cells, their 
high proliferative potential, self-renewal and multilinear 
differentiation potential has been described. DPSCs 
possess multilineage potential and plasticity, so they are 
able to differentiate into different kind of cells, such as 
osteoblasts, chondrocytes, adipocytes, muscle cells, neural 
cells, odontoblasts, cementoblasts and ameloblasts11. 
A growing number of niches containing significant 
number of stem cells have been identified within the 
human body, which represents a physiologic source of 
stem cells suitable for regeneration, transplantation and 
tissue-based therapies. Dental tissues, such as adult dental 
pulp, periodontal ligament and dental pulp from exfoliated 
deciduous teeth, are shown to be an approachable and 
large source of stem cells12. Stromal bone producing 
dental pulp stem cells (SBP-DPSCs) and stromal bone 
producing-stem cells from human exfoliated deciduous 
teeth (SBP-SHEDs) can produce tridimensional bone in 
in vitro conditions. This bone is woven but, after in vivo 
transplantation, it can be remodelled into lamelar bone8,13.
Dental Pulp Stem Cells
Dentine-pulp complex possess natural reparative 
and regenerative potential which enables formation of 
tertiary dentine3. After mild stimuli, such as attrition, 
erosion or superficial caries, odontoblasts secrete 
reactionary dentine matrix. However, intensive stimuli, 
such as trauma, advanced caries or extensive restaurative 
procedures, may cause death of odontoblasts and a 
cascade of specific signals and yet un-clarified events. 
This leads to high proliferation rate of progenitor/stem 
cells and their differentiation into new odontoblasts3,14-16. 
New odontoblasts secrete atubular reparative dentin or 
osteodentin17. This reparative dentine represents a layer of 
mineralised tissue that provides protection of pulp tissue 
vitality3. 
Postnatal pulp comprises several niches with 
potential progenitor/stem cells which may have a 
significant role in formation of reparatory dentine. 
This subpopulation of undifferentiated cells represents 
approximately 1% of total cell count, and it is inactive 
in healthy tissue environment. Although very small, this 
subpopulation has extremely high proliferative potential 
and multi/potential capacity to produce terminally 
differentiated cells in response to specific extracellular 
signals3,18.
DPSCs are important human stem cells source, 
especially in patients who lost their chance to isolate and 
preserve stem cells using umbilical cord blood samples, as 
this is one-time-only opportunity to obtain the specimen, 
at the time of birth18. However, dental banking offers 
convenience to harvest specimens during the period of 
mixed dentition. An important issue in DPSCs banking 
is limited in volume of dental pulp tissue within the 
tooth cavity. Therefore, possible progenitor/stem cells 
expansion after adequate method of preservation is very 
important as this may augment potential therapeutic use of 
DPSCs in regenerative medicine and dentistry19.
Stem Cell Preservation
As progenitor/stem cells became useful for tissue 
engineering and cell therapy applications, proper mode 
of their preservation also became important. Stem cells 
may be used immediately after isolation in only certain 
situations when allogenic transplantation procedures are 
applied. It is defined that progenitor/stem cell transfer from 
donor to recipient should be established within 72 hours. 
Therefore, in some cases, protocols for preliminary storage 
on supra-freezing temperatures can be used20. A long-
term preservation til potential therapeutic use demands 
cryopreservation of progenitor/stem cells. This method 
is proven to be safe without significant adverse outcomes 
regarding host reaction, graft failure and transplantation 
success.
The donor specimens are usually stored in public or 
private banks, which store donor specimens for the donor 
himself (private banks), or for an unknown matching 
recipient during indeterminate time period. Public banks 
are non-profit organizations that provide donor specimens 
to match recipients through national or international bank 
registries. Haematopoietic stem cells from umbilical cord 
blood have been extensively studied regarded to possible 
recovery and therapeutic use in stem cell transplantation 
procedures after cryopreservation21. Current data have 
shown that there are about 170 000 frozen units in 37 cord 
blood registries in 21 countries world wide20.
Cryopreservation Methods
There is no single and perfect cryopreservation 
method. During the past decade, different transplantation 
centres developed their individual techniques for long-
term preservation of progenitor/stem cells and their 
differentiated cells20,22-23. The identification, isolation and 
characterization of DPSCs, as an approachable human 
postnatal stem cells source, enabled their exploitation24,25. 
Therefore transplantation centres adjusted their methods 
for long-term preservation of  DPSCs as they became 
an approachable source of human stem cells for auto-
transplantation, tissue regeneration and tissue-based 
clinical therapies in humans9-10,13,26. Cryopreservation 
and recovery procedures are described and debated in the 
literature and the most important points in the procedure 
are: growth phase of harvested cells, number of cells (too 
low or too high cell number may decrease the recovery 
rate), the proper cryopreservative concentration and serum 
concentration18,20. The cryopreservation process includes 
the following general components:
 - Harvesting of the donor cells; 
 - Addition of the proper cryopreservatives;
 - The freezing procedure at the proper temperature 
and freezing rate;
 - The thawing procedure and
 - Assessment of the viability of the specimen prior to 
transplantation procedure.
Cryopreservation procedures undertake international 
recommendations and rules. The International Society for 
Cellular Therapy (ISCT) defined special gamma irradiated, 
ethinyl vinyl acetate based cryostorage container products 
in which the specimens should be preserved. It has been 
shown that the use of different containers, PVC and 
polyolefin plastic bags accomplished different results 
regarding the viability of specimens20. 
Cryopreservative is additive to stem cell 
concentrate, which intercepts formation of intracellular 
and extracellular crystals and consequent cell death. 
The standard cryopreservative is dimethyl sulfoxide 
(DMSO), which prevents cell lesions during freezing. It 
is usually used at concentrations of 1-20%, but common 
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concentration is 10% in combination with saline and serum 
albumin13,18,20,23,26-27. In vitro study proved that 10% 
DMSO was superior to lower concentrations28. However, 
proper DMSO concentration is debated in the current 
literature due to DMSO induced toxicity with significant 
side effects after transplantation of stem cells. Side effects, 
such as nausea, vomiting, cardiovascular, respiratory, 
CNS, hepatotoxic and haemolytic manifestations were 
reported20. Potential alternative preservation methods 
with possible future perspective could be propylene-
glycol, combination of alpha tocopherol, catalase, ascorbic 
acid and the glucose dimer trehalose, and addition of 
the caspase inhibitor zVAD-fmk20,29. However, the 
composition of the cryoprotective medium may be adapted 
to the respective tissue to be frozen and thus the method of 
preservation can be further adjusted23.
The storage temperatures used for cryopreservation 
of haematopoietic stem cells during the last decade 
have been -196ºC for storage in liquid nitrogen, -156ºC 
for storage in vapour nitrogen and -80ºC for storage in 
cryopreservation mechanical freezers20,23. Few authors 
described possible storage at supra-freezing temperature, 
at +4ºC30. Standard DPSCs preservation procedures 
described in the literature imply storage in liquid nitrogen 
at -196ºC and -80ºC9-10,13,20 or in mechanical freezers at 
-80ºC18. The cells are cooled in a controlled manner and it 
is possible to choose the point in time of intracellular ice 
formation at a temperature of approximately -7 to -12°C, 
preferably -10°C. In this way, the cells’ exposure to stress 
during the freezing process is reduced, and the number 
of viable stem cells is further increased. After the ice 
formation, the DPSCs can be cooled down in cooling rates 
to a temperature between -90°C and -160°C, or between 
-100°C and -150°C, or even between -120°C and -130°C 
if permanently storaged23.
Controlled thawing procedure considers gradual 
thawing and slow rates, which enables good after 
thawing recovery18,27. Regarding the survival rate of 
the cryopreserved DPSCs, it has been found important 
if the cells are thawed in several steps by dilution of the 
freezing medium23. The standard thawing technique is 
warming in a liquid medium at 35-39ºC, followed by 
washing or dilution, which reduces the cryopreservative 
content13,18,20,23. The dilution includes replacement of 
freezing medium with a medium containing 50%, 25%, 
12.5%, 6.25% and 0% foetal calf serum23.
Microbial contamination of transplants represents a 
significant hazard; therefore, infection must be eliminated 
before the beginning of cryopreservation method. 
There is the risk of contamination of the culture bottles, 
which is not induced by the donor graft, and therefore 
specific measures should be employed. Also, infected 
donor specimen must be aborted. In order to prevent 
contamination, there is a need for processing in absolutely 
clean areas with monitoring of stem cell preservation 
procedures and screening of donor specimens. 
Papaccio et al13 have proved that DPSCs and their 
differentiated cells can be safely recovered after long-term 
cryopreservation, prolonged for up to 2 years. However, 
cryopreservation of the whole dental pulp tissue has proven 
to be problematic. Papaccio et al13 obtained negative results 
for the cryopreservation of the whole dental pulp using 
a similar technique as Seo et al26 for minced periodontal 
ligament. This may be the consequence of higher water 
content in the dental pulp, which is a mucus connective 
tissue13. Therefore, a different cryopreservation procedure 
is necessary for the whole pulp.
Conclusions
While cryopreservation of isolated and expanded 
DPSCs has proven to be a safe procedure, storage of 
primary tissue has shown small recovery rate10,13,26. 
Investigation of different cryopreservation methods could 
provide evidence about ideal and uniform technique for 
long-term preservation. Ideal cryopreservation method 
should provide storage of whole primary tissue and 
possible isolation, recovery, viability and functionality 
of DPSCs after thawing, compared to cells isolated from 
fresh tissue. This idea has the practical and reasonable 
advantages, because cryopreservation of the tissue 
specimens in the clinic where they were harvested would 
be less costly and more effective than direct isolation and 
preservation of stem cells, which may require additional 
equipment and professional personnel. There is necessary 
for further investigations regarding capability of DPSCs 
and their differentiated cells to recover and restart 
proliferation, differentiation and new tissue production for 
therapeutic use after cryopreservation.
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